PharmAust Limited
ASX:PAA.AX
0.23 (AUD) • At close October 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 2.824 | 3.381 | 2.14 | 3.196 | 4.347 | 3.259 | 3.308 | 2.718 | 2.371 | 1.939 | 1.71 | 1.618 | 1.552 | 1.641 | 1.756 | 2.795 | 7.131 | 6.106 | 3.211 | 0.306 | 0.068 | 0.678 | 0 |
Cost of Revenue
| 0.002 | 3.753 | 3.605 | 2.912 | 3.62 | 0.334 | 0.289 | 0.341 | 0.234 | 0.208 | 0.223 | 0.221 | 0.177 | 0.142 | 0.209 | 0.194 | 0.711 | 3.018 | 1.841 | 1.318 | 0.139 | 0.035 | 0.148 | 0 |
Gross Profit
| -0.002 | -0.93 | -0.224 | -0.772 | -0.424 | 4.013 | 2.97 | 2.967 | 2.484 | 2.164 | 1.717 | 1.49 | 1.441 | 1.41 | 1.431 | 1.562 | 2.083 | 4.113 | 4.265 | 1.893 | 0.167 | 0.033 | 0.53 | 0 |
Gross Profit Ratio
| 0 | -0.329 | -0.066 | -0.36 | -0.133 | 0.923 | 0.911 | 0.897 | 0.914 | 0.912 | 0.885 | 0.871 | 0.891 | 0.908 | 0.872 | 0.89 | 0.746 | 0.577 | 0.698 | 0.59 | 0.547 | 0.482 | 0.781 | 0 |
Reseach & Development Expenses
| 3.847 | 1.032 | 0.759 | 0.554 | 0.605 | 1.039 | 0.464 | 0.329 | 0.702 | 0.629 | 0.212 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.053 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 1.661 | 1.767 | 1.464 | 1.142 | 1.409 | 1.355 | 1.302 | 1.747 | 1.247 | 1.109 | 2.053 | 2.237 | 2.18 | 2.003 | 1.914 | 2.08 | 4.903 | 4.547 | 3.634 | 1.059 | 1.426 | 1.63 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 2.914 | 3.562 | 2.523 | 1.777 | 2.18 | 1.725 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.783 | 0 |
SG&A
| 2.81 | 1.661 | 1.767 | 1.464 | 1.142 | 4.323 | 4.917 | 3.825 | 3.525 | 3.427 | 2.833 | 2.053 | 2.237 | 2.18 | 2.003 | 1.914 | 2.08 | 4.903 | 4.547 | 3.634 | 1.059 | 1.426 | 2.413 | 0 |
Other Expenses
| 0 | 0.995 | 1.129 | 1.517 | 0.924 | 0.676 | 0.388 | 0.453 | 0.7 | 0.502 | 0.059 | 0.053 | 3.432 | 0.01 | 0.122 | 1.816 | -0.803 | 0.003 | 0.743 | 0.022 | 0.044 | 0.089 | -3.723 | -2.382 |
Operating Expenses
| 6.657 | 2.693 | 2.526 | 2.018 | 1.747 | 5.534 | 5.5 | 4.277 | 6.408 | 4.134 | 3.1 | 2.106 | 5.669 | 2.249 | 2.065 | 2.184 | 4.649 | 10.47 | 7.58 | 3.861 | 1.337 | 2.096 | 0.578 | 0.251 |
Operating Income
| -6.659 | -3.623 | -2.749 | -2.79 | -2.171 | -1.521 | -2.53 | -1.31 | -1.853 | -1.97 | -1.383 | -0.616 | -4.228 | -5.837 | -0.634 | -0.622 | -2.565 | -6.302 | -3.315 | -1.817 | -0.993 | -1.974 | -3.725 | -0.251 |
Operating Income Ratio
| 0 | -1.283 | -0.813 | -1.303 | -0.679 | -0.35 | -0.776 | -0.396 | -0.682 | -0.831 | -0.713 | -0.36 | -2.613 | -3.76 | -0.386 | -0.354 | -0.918 | -0.884 | -0.543 | -0.566 | -3.24 | -29.044 | -5.493 | 0 |
Total Other Income Expenses Net
| -2.795 | -2.589 | 1.041 | 1.452 | 0.809 | -0.03 | 0.009 | -0.033 | -2.075 | 0.045 | 0.065 | -0.023 | -0.033 | -4.989 | 0.122 | 0.426 | -3.138 | 0.003 | 0.593 | -1.289 | -1.266 | 0.089 | -3.723 | -2.382 |
Income Before Tax
| -9.453 | -6.212 | -1.708 | -1.337 | -1.362 | -1.551 | -2.522 | -1.344 | -3.927 | -1.925 | -1.318 | -0.639 | -4.26 | -5.798 | -0.439 | -0.18 | -5.768 | -6.575 | -2.752 | -3.364 | -2.585 | -2.073 | -3.705 | -2.094 |
Income Before Tax Ratio
| 0 | -2.2 | -0.505 | -0.625 | -0.426 | -0.357 | -0.774 | -0.406 | -1.445 | -0.812 | -0.68 | -0.374 | -2.633 | -3.735 | -0.267 | -0.102 | -2.064 | -0.922 | -0.451 | -1.048 | -8.434 | -30.5 | -5.465 | 0 |
Income Tax Expense
| -0.553 | 0 | 0 | -0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | -0.114 | 0.008 | 0.014 | 0.228 | 0.57 | -2.232 | 0.283 | 0.82 | -3.364 | -2.585 | -2.073 | -3.705 | -2.094 |
Net Income
| -9.032 | -6.212 | -1.708 | -1.337 | -1.362 | -1.551 | -2.522 | -1.344 | -3.927 | -1.925 | -1.318 | -0.515 | -4.26 | -5.798 | -0.439 | -0.18 | -5.768 | -6.575 | -2.752 | -3.364 | 0.037 | -2.073 | -3.705 | -2.094 |
Net Income Ratio
| 0 | -2.2 | -0.505 | -0.625 | -0.426 | -0.357 | -0.774 | -0.406 | -1.445 | -0.812 | -0.68 | -0.301 | -2.633 | -3.735 | -0.267 | -0.102 | -2.064 | -0.922 | -0.451 | -1.048 | 0.12 | -30.5 | -5.465 | 0 |
EPS
| -0.024 | -0.019 | -0.005 | -0.004 | -0.005 | -0.007 | -0.017 | -0.011 | -0.043 | -0.025 | -0.02 | -0.017 | -0.16 | -0.36 | -0.03 | -0.013 | -0.48 | -1.05 | -0.61 | -1 | -1.35 | -1.58 | -3.44 | -2.58 |
EPS Diluted
| -0.024 | -0.019 | -0.005 | -0.004 | -0.005 | -0.007 | -0.017 | -0.011 | -0.043 | -0.025 | -0.02 | -0.017 | -0.16 | -0.36 | -0.03 | -0.013 | -0.48 | -1.05 | -0.61 | -1 | -1.35 | -1.58 | -3.44 | -2.58 |
EBITDA
| -6.657 | -3.296 | -2.434 | -2.491 | -1.896 | -1.349 | -2.412 | -1.187 | -1.743 | -1.893 | -1.33 | -0.557 | -4.162 | -0.73 | -0.271 | 0.022 | -4.566 | -5.485 | -2.106 | -1.924 | -1.02 | -1.283 | -3.045 | -1.844 |
EBITDA Ratio
| 0 | -1.167 | -0.72 | -1.164 | -0.593 | -0.31 | -0.74 | -0.359 | -0.641 | -0.798 | -0.686 | -0.326 | -2.573 | -0.47 | -0.165 | 0.013 | -1.634 | -0.769 | -0.345 | -0.599 | -3.33 | -18.874 | -4.491 | 0 |